# TransMedics acquires EVOSS and LifeCradle technologies from Bridge to Life

TransMedics Group has acquired from Bridge to Life Ltd. the assets and intellectual property related to the EVOSS warm perfusion technology and LifeCradle cold perfusion technology for organ transplantation.

- Type: Acquisition
- Announced: 2023-08-02
- Where: United States
- Status: completed
- Products: EVOSS warm perfusion technology, LifeCradle cold perfusion technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bridge to Life](https://endata.com/companies/53131.md) (target)
- [TransMedics Group](https://endata.com/companies/71806.md) (acquirer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/transmedics-acquires-warm-perfusion-evoss-and-cold-perfusion-lifecradle-technologies-from-bridge-to-life-301892032.html), 2023-08-02: "TransMedics Group, Inc. announced today that is has acquired from Bridge to Life Ltd., assets and intellectual property related to the Ex-Vivo Organ Support System and LifeCradle Heart Preservation Transport System technologies."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.